Prompt Diagnosis and Effective Treatment of Trichosporon asahii Catheter-Related Infection in Non-immunocompromised Neurosurgical Patient

Mycopathologia

Volumn 179, Issue 1-2, 2015, Pages 125-128

  Rubic, Zana ^a,b   Novak, Anita ^a,b   Tomic, Zvonimir ^a   Goic Barisic, Ivana ^a,b   Radic, Marina ^a,b   Tonkic, Marija ^a,b  

^a UNIVERSITY HOSPITAL SPLIT   (Croatia)

^b UNIVERSITY OF SPLIT   (Croatia)

Author keywords

Catheter related infection; Non immunocompromised patient; Trichosporon; Voriconazole

Indexed keywords

ANTIFUNGAL AGENT; VORICONAZOLE;

ADVERSE EFFECTS; AGED; CASE REPORT; CATHETER-RELATED INFECTIONS; COMA; CROSS INFECTION; DRUG EFFECTS; HUMAN; MALE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; NEUROSURGERY; TREATMENT OUTCOME; TRICHOSPORON; TRICHOSPORONOSIS;

AGED; ANTIFUNGAL AGENTS; CATHETER-RELATED INFECTIONS; COMA; CROSS INFECTION; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; NEUROSURGICAL PROCEDURES; TREATMENT OUTCOME; TRICHOSPORON; TRICHOSPORONOSIS; VORICONAZOLE;

EID: 84925482111     PISSN: 0301486X     EISSN: 15730832     Source Type: Journal    
DOI: 10.1007/s11046-014-9814-9     Document Type: Review

References (22)

1. Haupt HM, Merz WG, Beschorner WE, Vaughan WP, Saral R. Colonization and infection with Trichosporon species in the immunosuppressed host. J Infect Dis. 1983;147:199–203.
2. Chagas-Neto TC, Chaves GM, Columbo AL. Update on genus Trichosporon. Mycopathologia. 2008;166(3):121–32.
3. Gueho E, Improvisi L, de Hoog GS, Dupont B. Trichosporon on humans: a practical account. Mycoses. 1994;37:3–10.
4. Netsvyetayeva I, Swoboda-Kopec E, Paczek L, Fiedor P, Sikora M, Jaworska-Zaremba M, Blachnio S, Luczak M. Trichosporon asahii as a prospective pathogen in solid organ transplant recipients. Mycoses. 2009;52:263–5.
5. Dua V, Yadav SP, Oberoi J, Sachdeva A. Successful treatment of Trichosporon asahii infection with voriconazole after bone marrow transplant. J Pediatr Hematol Oncol. 2013;35(3):237–8.
6. Ozkaya-Parlakay A, Karadag-Oncel E, Cengiz AB, Kara A, Yigit A, Gucer S, Gur D. Trichosporon asahii sepsis in a patient with pediatric malignancy. J Microbiol Immunol Infect. 2013 Feb 15. pii: S1684-1182(13)00018-2. doi:10.1016/j.jmii.2013.01.003.
7. Isenberg HD. Catheter Tip Cultures, in: Clinical Microbiology Procedures Handbook. 2nd edition. Washington, DC: American Society for Microbiology, 2007; 3.6.1–3.6.6.
8. Ebright JR, Fairfax MR, Vazquez JA. Trichosporon asahii, a non-Candida yeast that caused fatal septic shock in a patient without cancer or neutropenia. Clin Infect Dis. 2001;33(5):E28–30.
9. Di Bonaventura G, Pompilio A, Picciani C, Iezzi M, D’Antonio D, Piccolomini R. Biofilm formation by the emerging fungal pathogen Trichosporon asahii: development, architecture, and antifungal resistance. Antimicrob Agents Chemother. 2006;50(10):3269–76.
10. Sun W, Su J, Xu S, Yan D. Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing. J Med Microbiol. 2012;61:1750–7.
11. Clancy CJ, Nquyen MH. Finding the “missing 50 %” of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care. Clin Infect Dis. 2013;56(9):1284–92.
12. Rastogi VL, Nirwan PS. Invasive trichosporonosis due to Trichosporon asahii in a non-immunocompromised host: a rare case report. Indian J Med Microbiol. 2007;25(1):59–61.
13. Kim YJ, Kim SI, Kim YR, Park YM, Park YJ, Kang MW. Successful treatment of septic shock with purpura fulminans caused by Trichosporon asahii in an immunocompetent patient. Ann Clin Lab Sci. 2007;37(4):366–9.
14. Suzuki K, Nakase K, Kyo T, Kohara T, Sugawara Y, Shibazaki T, Oka K, Tsukada T, Katayama N. Fatal Trichosporon fungemia in patients with hematologic malignancies. Eur J Haematol. 2010;84(5):441–7.
15. Shang ST, Yang YS, Peng MY. Nosocomial Trichosporonasahii fungemia in a patient with secondary hemochromatosis: a rare case report. J Microbiol Immunol Infect. 2010;43(1):77–80.
16. Girmenia C, Pagano L, Martino B, D’Antonio D, Fanci R, Specchia G, Melillo L, Buelli M, Pizzarelli G, Venditti M, Martino P. GIMEMA Infection Program. Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature. J Clin Microbiol. 2005;43(4):1818–28.
17. Wolf DG, Falk R, Hacham M, Theelen B, Boekhout T, Scorzetti G, Shapiro M, Block C, Salkin IF, Polacheck I. Multidrug-resistant Trichosporon asahii infection of nongranulocytopenic patients in three intensive care units. J Clin Microbiol. 2001;39(12):4420–5.
18. Asada N, Uryu H, Koseki M, Takeuchi M, Komatsu M, Matsue K. Successful treatment of breakthrough Trichosporon asahii fungemia with voriconazole in a patient with acute myeloid leukemia. Clin Infect Dis. 2006;43:e39–41.
19. Matsue K, Uryu H, Koseki M, Asada N, Takeuchi M. Breakthrough trichosporonosis in patients with hematologic malignancies receiving micafungin. Clin Infect Dis. 2006;42:753–7.
20. Rodriguez-Tudela JL, Diaz-Guerra TM, Mellado E, Cano V, Tapia C, Perkins A, Gomez-Lopez A, Rodero L, Cuenca-Estrella M. Susceptibility patterns and molecular identification of Trichosporon species. Antimicrob Agents Chemother. 2005;49:4026–34.
21. Bayramoglu G, Sonmez M, Tosun I, Aydin K, Aydin F. Breakthrough Trichosporon asahii fungemia in neutropenic patient with acute leukemia while receiving caspofungin. Infection. 2008;36:68–70.
22. ESCMID EFISG study group and ECMM. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections. Clin Microbiol Infect. 2014;20(Suppl 3):76–98.